HEPION PHARMACEUTICALS, INC. Preferred Stock, Shares Authorized
HEPION PHARMACEUTICALS, INC. (HEPA) had Preferred Stock, Shares Authorized of 20.00 million shares as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2014-11-13
- 2014-09-30: Preferred Stock, Shares Authorized 20.00M shares.
- 2014-06-30: Preferred Stock, Shares Authorized 20.00M shares.
- 2014-03-31: Preferred Stock, Shares Authorized 20.00M shares.
- 2013-12-31: Preferred Stock, Shares Authorized 20.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2014-09-30 | 20.00M shares 10-Q · filed 2014-11-13 |
| 2014-06-30 | 20.00M shares 10-Q · filed 2014-11-13 |
| 2014-03-31 | 20.00M shares 10-Q · filed 2014-05-15 |
| 2013-12-31 | 20.00M shares 10-Q · filed 2014-02-05 |
| 2013-09-30 | 20.00M shares 10-Q · filed 2013-11-19 |
| 2013-06-30 | 20.00M shares 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |